Stockscreener 앱 받기
0.00%
시간 외 거래:
전일 마감가:
$25.04
열려 있는:
$25.01
하루 거래량:
46.68M
Relative Volume:
0.69
시가총액:
$142.37B
수익:
$62.79B
순이익/손실:
$9.84B
주가수익비율:
14.60
EPS:
1.7156
순현금흐름:
$10.38B
1주 성능:
-2.95%
1개월 성능:
-1.61%
6개월 성능:
+4.86%
1년 성능:
-3.28%
1일 변동 폭
$24.98
$25.23
1주일 범위
$24.92
$26.65
52주 변동 폭
$20.91
$27.69
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
PFE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
25.04 | 142.37B | 62.79B | 9.84B | 10.38B | 1.7156 |
|
LLY
Lilly Eli Co
|
1,056.88 | 932.42B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
208.31 | 506.75B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
222.82 | 396.44B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
135.27 | 259.09B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
100.69 | 246.17B | 63.90B | 19.05B | 13.05B | 7.5596 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Citigroup | Neutral |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Pfizer Stock After Hours Today (Dec. 18, 2025): PFE Holds Near $25 — What to Know Before Friday’s Market Open - ts2.tech
Pfizer Slashes Guidance, Faces Patent Cliff—Is the Worst Yet to Come? - Smartkarma
Can Pfizer Inc. stock hit analyst price targetsQuarterly Market Summary & Fast Gaining Stock Reports - Улправда
Pfizer’s birth control injection has a new safety label, reflecting potential brain tumors - Medical Marketing and Media
Better Buy in 2026: Pfizer or Eli Lilly? - AOL.com
How Pfizer Inc. stock reacts to Fed rate cutsWeekly Market Report & Consistent Income Trade Recommendations - Улправда
Pfizer’s New Liver Cancer Trial Signals a Longer-Term Oncology Upside for PFE - TipRanks
White House Readies Drug Price Deals With AbbVie, Novartis, Roche - Benzinga
Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts - The AI Journal
Industry Comparison: Evaluating Pfizer Against Competitors In Pharmaceuticals Industry - Benzinga
Federal lawsuit accuses Teva of colluding with Pfizer to delay releasing generic drugs - The Business Journals
Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts - ts2.tech
Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun - Benzinga
Fiduciary Alliance LLC Has $3.70 Million Position in Pfizer Inc. $PFE - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Has Affirmed Its Dividend Of $0.43 - simplywall.st
Czech National Bank Purchases 54,306 Shares of Pfizer Inc. $PFE - MarketBeat
Gradient Investments LLC Has $4.09 Million Stake in Pfizer Inc. $PFE - MarketBeat
Astellas, Pfizer Combo Shows Survival Gains In Early-Stage Bladder Cancer Trial - marketscreener.com
Pfizer Stock (PFE) After Hours Today (Dec. 17, 2025): What to Know Before the Market Opens Thursday - ts2.tech
Pfizer CEO Says US Vaccine Policy Changes A Political ‘Anomaly’ - Citeline News & Insights
Pfizer (NYSE:PFE) Trading Down 1.9%Time to Sell? - MarketBeat
Pfizer Inc (PFE) rating steady amid neutral market outlook and pipeline progress - MSN
Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress - Finviz
Analysts’ Top Healthcare Picks: Pfizer (PFE), Novan (NOVN) - The Globe and Mail
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025) - ts2.tech
Pfizer: Ignoring The Dead Cat Bounce (NYSE:PFE) - Seeking Alpha
Pfizer: 2026 Feels Like Another Lost Year After Yesterday's Guidance Update (NYSE:PFE) - Seeking Alpha
Company News for Dec 17, 2025 - The Globe and Mail
Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future? - The Globe and Mail
Pfizer, Merck Are Boring Again: 2026 Investors Are Circling BackMerck & Co (NYSE:MRK), Pfizer (NYSE:PFE) - Benzinga
The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now - Finviz
Guggenheim maintains Buy rating on Pfizer stock, sets $35 price target - Investing.com Canada
Pfizer Stock (PFE) Slips After 2026 Outlook: Guidance, Analyst Forecasts, Dividend Update, and Key Catalysts to Watch on Dec. 17, 2025 - ts2.tech
Quintet Private Bank Europe S.A. Raises Position in Pfizer Inc. $PFE - MarketBeat
Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck’s Keytruda - Seeking Alpha
Pfizer says phase 3 EV-304 clinical trial meets primary endpoint - marketscreener.com
Pfizer shares slide on pessimistic projections - The Pharma Letter
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance - BioSpace
Wolfe Research Adjusts Price Target on Pfizer to $24 From $25, Maintains Underperform Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Pfizer to $27 From $28, Maintains Equalweight Rating - marketscreener.com
Pfizer stock price target lowered to $24 at Wolfe Research on underperformance - Investing.com Canada
Thrivent Financial for Lutherans Increases Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Stock Fell 3.4% Yesterday On Modest 2026 Outlook - TIKR.com
Corient Private Wealth LLC Sells 179,789 Shares of Pfizer Inc. $PFE - MarketBeat
Assenagon Asset Management S.A. Purchases 3,722,531 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Stock on the Edge: 3 Threats You Need to Know - Trefis
Pfizer : Analyst and Investor Call to Review Pfizer Full-Year 2026 Financial Guidance Transcript - marketscreener.com
Tilray Brands, Pfizer, Netflix, Lennar Corp. And Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts - ts2.tech
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.31%
자본화:
|
볼륨(24시간):